Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis. Issue 1 (1st April 2015) - Ramos, J M; Vidal, I; Bellot, P; Gómez-Hurtado, I; Zapater, P; Such, J